BioCentriq announces it has completed the construction of a state of the art GMP-ready clinical manufacturing facility in South Brunswick, New Jersey. The new...
The first molecular electronics chip has been developed, realizing a 50-year-old goal of integrating single molecules into circuits to achieve the ultimate scaling limits...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Australia's Therapeutic Goods Administration (TGA)...
